Moderna

Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData

Read more

Moderna COVID-19 vaccine Spikevax sales to reduce amid strong competition: GlobalData

Read more

Davos 2023: Moderna CEO says he wants to have MRNA factory on every continent

Read more

Moderna says RSV vaccine 84 per cent effective at preventing symptoms in older adults

Read more

Sen Sanders asks Moderna not to hike COVID vaccine price

Read more

Moderna COVID vaccine sales forecasts fall short for 2022, 2023

Read more

EMA recommends Moderna’s updated Omicron-tailored vaccine

Read more

Moderna says Omicron booster response stays high through three months

Read more

Moderna to supply 12 million doses of Omicron-targetted COVID shot to Canada

Read more

UK first to approve Omicron COVID shot with Moderna nod

Read more